China Medical System Holdings Limited
Simbolis: CHSYF
PNK
0.9313
USDRinkos kaina šiandien
6.8671
P/E santykis
0.0000
PEG koeficientas
2.28B
MRK kapitalizacija
- 0.01%
DIV pajamingumas
China Medical System Holdings Limited (CHSYF) Finansinės ataskaitos
Balansas
common:word.in-mln USD Growth | TTM | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | |||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
balance-sheet.row.cash-and-short-term-investments | 23343.58 | 6143.3 | 5867.7 | 4363.6 | ||||||||||||||||||
balance-sheet.row.short-term-investments | 6185.67 | 1832.3 | 1491.3 | 977.9 | ||||||||||||||||||
balance-sheet.row.net-receivables | 8038.05 | 1735.9 | 2039.7 | 2169.2 | ||||||||||||||||||
balance-sheet.row.inventory | 2321.75 | 637.6 | 477.2 | 472.6 | ||||||||||||||||||
balance-sheet.row.other-current-assets | 7909.02 | 2109.9 | 1936.1 | 1352.2 | ||||||||||||||||||
balance-sheet.row.total-current-assets | 35426.73 | 8794.4 | 8829.4 | 7379.7 | ||||||||||||||||||
balance-sheet.row.property-plant-equipment-net | 1955.04 | 473.7 | 495.5 | 544.9 | ||||||||||||||||||
balance-sheet.row.goodwill | 6485.24 | 1547.9 | 1666 | 1691.2 | ||||||||||||||||||
balance-sheet.row.intangible-assets | 11939.35 | 2246.1 | 3351.8 | 3006.2 | ||||||||||||||||||
balance-sheet.row.goodwill-and-intangible-assets | 18424.6 | 3794 | 5017.8 | 4697.4 | ||||||||||||||||||
balance-sheet.row.long-term-investments | 7584.18 | 1782.6 | 1850.5 | 2109.9 | ||||||||||||||||||
balance-sheet.row.tax-assets | 171.35 | 40.4 | 39 | 36.3 | ||||||||||||||||||
balance-sheet.row.other-non-current-assets | 7292.62 | 2845.7 | 1521.3 | 1039.8 | ||||||||||||||||||
balance-sheet.row.total-non-current-assets | 35427.8 | 8936.4 | 8924.2 | 8428.2 | ||||||||||||||||||
balance-sheet.row.other-assets | 0 | 0 | 0 | 0 | ||||||||||||||||||
balance-sheet.row.total-assets | 70854.52 | 17730.8 | 17753.5 | 15807.9 | ||||||||||||||||||
balance-sheet.row.account-payables | 698.58 | 141.7 | 178 | 145.9 | ||||||||||||||||||
balance-sheet.row.short-term-debt | 6164.63 | 1285.1 | 1799.1 | 1120.7 | ||||||||||||||||||
balance-sheet.row.tax-payables | 1584.26 | 317 | 389.1 | 343.3 | ||||||||||||||||||
balance-sheet.row.long-term-debt-total | 74.96 | 16.7 | 13.5 | 591.6 | ||||||||||||||||||
Deferred Revenue Non Current | -58.76 | -109 | 0 | 163.7 | ||||||||||||||||||
balance-sheet.row.deferred-tax-liabilities-non-current | 479.4 | - | - | - | ||||||||||||||||||
balance-sheet.row.other-current-liab | 681.26 | 1 | 1 | 2 | ||||||||||||||||||
balance-sheet.row.total-non-current-liabilities | 714.19 | 125.6 | 139.4 | 879.6 | ||||||||||||||||||
balance-sheet.row.other-liabilities | 0 | 0 | 0 | 0 | ||||||||||||||||||
balance-sheet.row.capital-lease-obligations | 134.28 | 32.1 | 29.3 | 34.7 | ||||||||||||||||||
balance-sheet.row.total-liab | 10571.6 | 2174.4 | 3016.5 | 2960.9 | ||||||||||||||||||
balance-sheet.row.preferred-stock | 601.22 | 287.4 | 112.7 | 35.6 | ||||||||||||||||||
balance-sheet.row.common-stock | 335.99 | 84 | 84 | 84.2 | ||||||||||||||||||
balance-sheet.row.retained-earnings | 50802.22 | 13426 | 12512.2 | 10550.1 | ||||||||||||||||||
balance-sheet.row.accumulated-other-comprehensive-income-loss | -601.22 | -287.4 | -112.7 | -35.6 | ||||||||||||||||||
balance-sheet.row.other-total-stockholders-equity | 8787.69 | 2010.3 | 1992.9 | 2118.2 | ||||||||||||||||||
balance-sheet.row.total-stockholders-equity | 59925.9 | 15520.2 | 14589.1 | 12752.4 | ||||||||||||||||||
balance-sheet.row.total-liabilities-and-stockholders-equity | 70854.52 | 17730.8 | 17753.5 | 15807.9 | ||||||||||||||||||
balance-sheet.row.minority-interest | 357.03 | 36.2 | 148 | 94.5 | ||||||||||||||||||
balance-sheet.row.total-equity | 60282.93 | 15556.4 | 14737.1 | 12847 | ||||||||||||||||||
balance-sheet.row.total-liabilities-and-total-equity | 70854.52 | - | - | - | ||||||||||||||||||
Total Investments | 13769.85 | 3614.9 | 3341.9 | 3087.8 | ||||||||||||||||||
balance-sheet.row.total-debt | 6239.59 | 1301.7 | 1812.6 | 1712.3 | ||||||||||||||||||
balance-sheet.row.net-debt | -10918.33 | -3009.3 | -2563.7 | -1673.4 |
Pinigų srautų ataskaita
common:word.in-mln USD Growth | TTM | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | |||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
cash-flows.row.net-income | 830 | 2873.8 | 3762.8 | 3456.6 | ||||||||||||||||||
cash-flows.row.depreciation-and-amortization | 63.47 | 229.6 | 227.2 | 219.8 | ||||||||||||||||||
cash-flows.row.deferred-income-tax | 0 | -467.4 | -489.2 | -548.1 | ||||||||||||||||||
cash-flows.row.stock-based-compensation | 0 | -35.9 | 18.7 | 17.2 | ||||||||||||||||||
cash-flows.row.change-in-working-capital | 0 | 3 | 90.1 | -596.1 | ||||||||||||||||||
cash-flows.row.account-receivables | 0 | 410.6 | 163.9 | -367.9 | ||||||||||||||||||
cash-flows.row.inventory | 0 | -235.8 | 8.2 | -90.9 | ||||||||||||||||||
cash-flows.row.account-payables | 0 | -410.6 | -163.9 | 367.9 | ||||||||||||||||||
cash-flows.row.other-working-capital | 0 | 238.7 | 81.9 | -505.2 | ||||||||||||||||||
cash-flows.row.other-non-cash-items | 145.19 | -100.2 | -56.4 | -55.5 | ||||||||||||||||||
cash-flows.row.net-cash-provided-by-operating-activities | 911.72 | 0 | 0 | 0 | ||||||||||||||||||
cash-flows.row.investments-in-property-plant-an-equipment | -119.26 | -318 | -524.9 | -184.8 | ||||||||||||||||||
cash-flows.row.acquisitions-net | -0.52 | -123.6 | -298.8 | -563.9 | ||||||||||||||||||
cash-flows.row.purchases-of-investments | -172.32 | -378 | -459.3 | -868.5 | ||||||||||||||||||
cash-flows.row.sales-maturities-of-investments | 3.25 | 20.3 | 3 | -61.3 | ||||||||||||||||||
cash-flows.row.other-investing-activites | -5.15 | 357 | 101.8 | 159 | ||||||||||||||||||
cash-flows.row.net-cash-used-for-investing-activites | -294 | -442.3 | -1178.2 | -1519.5 | ||||||||||||||||||
cash-flows.row.debt-repayment | -88.09 | -1786.7 | -1428 | 0 | ||||||||||||||||||
cash-flows.row.common-stock-issued | -2.41 | 0 | 1320.6 | 0 | ||||||||||||||||||
cash-flows.row.common-stock-repurchased | -23 | 0 | -48.4 | -151.5 | ||||||||||||||||||
cash-flows.row.dividends-paid | -370.76 | -1360.4 | -1276.2 | -1154.8 | ||||||||||||||||||
cash-flows.row.other-financing-activites | -10.46 | -117.3 | 32.1 | 1048 | ||||||||||||||||||
cash-flows.row.net-cash-used-provided-by-financing-activities | -487.05 | -2125 | -1399.9 | -258.4 | ||||||||||||||||||
cash-flows.row.effect-of-forex-changes-on-cash | -54.05 | -0.9 | 15.5 | 1.4 | ||||||||||||||||||
cash-flows.row.net-change-in-cash | 76.61 | -65.3 | 990.6 | 717.3 | ||||||||||||||||||
cash-flows.row.cash-at-end-of-period | 2449.49 | 4311.1 | 4376.4 | 3385.7 | ||||||||||||||||||
cash-flows.row.cash-at-beginning-of-period | 2372.88 | 4376.4 | 3385.7 | 2668.4 | ||||||||||||||||||
cash-flows.row.operating-cash-flow | 911.72 | 2502.9 | 3553.2 | 2493.9 | ||||||||||||||||||
cash-flows.row.capital-expenditure | -119.26 | -318 | -524.9 | -184.8 | ||||||||||||||||||
cash-flows.row.free-cash-flow | 792.46 | 2184.9 | 3028.3 | 2309 |
Pajamų ataskaitos eilutė
common:word.in-mln USD Growth | TTM | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | |||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
income-statement-row.row.total-revenue | 17163.63 | 8013.3 | 9150.3 | 8337.2 | ||||||||||||||||||
income-statement-row.row.cost-of-revenue | 4051.83 | 1904.1 | 2114.5 | 2090.3 | ||||||||||||||||||
income-statement-row.row.gross-profit | 13111.8 | 6109.2 | 7035.8 | 6246.9 | ||||||||||||||||||
income-statement-row.row.gross-profit-ratio | 0 | 0 | 0 | 0 | ||||||||||||||||||
income-statement-row.row.research-development | 320.56 | - | - | - | ||||||||||||||||||
income-statement-row.row.selling-general-administrative | 1293.24 | - | - | - | ||||||||||||||||||
income-statement-row.row.selling-and-marketing-expenses | 5232.65 | - | - | - | ||||||||||||||||||
income-statement-row.row.other-expenses | 0 | -6.5 | -7.5 | 1.6 | ||||||||||||||||||
income-statement-row.row.operating-expenses | 6662.45 | 3277.5 | 3390.3 | 3030.8 | ||||||||||||||||||
income-statement-row.row.cost-and-expenses | 10714.28 | 5181.6 | 5504.8 | 5121.1 | ||||||||||||||||||
income-statement-row.row.interest-income | 187.27 | 146.5 | 105.5 | 81.9 | ||||||||||||||||||
income-statement-row.row.interest-expense | 0 | 46.3 | 49.1 | 28.3 | ||||||||||||||||||
income-statement-row.row.selling-and-marketing-expenses | 5232.65 | - | - | - | ||||||||||||||||||
income-statement-row.row.total-other-income-expensenet | 371.28 | -437.9 | 140.4 | 79 | ||||||||||||||||||
income-statement-row.row.ebitda-ratio-caps | 0 | - | - | - | ||||||||||||||||||
income-statement-row.row.other-operating-expenses | 0 | -6.5 | -7.5 | 1.6 | ||||||||||||||||||
income-statement-row.row.total-operating-expenses | 371.28 | -437.9 | 140.4 | 79 | ||||||||||||||||||
income-statement-row.row.interest-expense | 0 | 46.3 | 49.1 | 28.3 | ||||||||||||||||||
income-statement-row.row.depreciation-and-amortization | 418.38 | 229.6 | 227.2 | 219.8 | ||||||||||||||||||
income-statement-row.row.ebitda-caps | 6683.72 | - | - | - | ||||||||||||||||||
income-statement-row.row.operating-income | 6265.34 | 3311.7 | 3622.4 | 3377.6 | ||||||||||||||||||
income-statement-row.row.income-before-tax | 6636.62 | 2873.8 | 3762.8 | 3456.6 | ||||||||||||||||||
income-statement-row.row.income-tax-expense | 976 | 489.3 | 486.7 | 431.3 | ||||||||||||||||||
income-statement-row.row.net-income | 5659.93 | 2400.9 | 3259 | 3017.4 |
Dažnai užduodami klausimai
Kas yra China Medical System Holdings Limited (CHSYF) bendras turtas?
China Medical System Holdings Limited (CHSYF) bendras turtas yra 17730837000.000.
Kokios yra įmonės metinės pajamos?
Metinės pajamos yra 8013285000.000.
Kokia yra įmonės pelno marža?
Įmonės pelno marža yra 0.758.
Koks yra įmonės laisvųjų pinigų srautas?
Laisvųjų pinigų srautas yra 0.141.
Kokia yra įmonės grynojo pelno marža?
Grynojo pelno marža yra 0.300.
Kokios yra bendros įmonės pajamos?
Bendrosios pajamos yra 0.339.
Kas yra China Medical System Holdings Limited (CHSYF) grynasis pelnas (grynosios pajamos)?
Grynasis pelnas (grynosios pajamos) yra 2400940000.000.
Kokia yra bendra įmonės skola?
Bendra skola yra 1301737000.000.
Koks yra veiklos sąnaudų skaičius?
Veiklos sąnaudos yra 3277487000.000.
Koks yra įmonės grynųjų pinigų skaičius?
Įmonės grynieji pinigai yra 4311058000.000.